Results 121 to 130 of about 31,480,937 (161)

Shared HLA-E and Mamu-E Peptide Repertoires With Subtle Peptide Binding Differences Revealed by Combined nDSF- and Fluorescence Polarisation-Based Methods. [PDF]

Eur J Immunol
Quastel MN, Ranawana SA, Peeters BWA, van Hateren A, McMichael AJ, Gillespie GM.   +5 more
europepmc   +1 more source

HLA-E: Immune Receptor Functional Mechanisms Revealed by Structural Studies. [PDF]

Immunol Rev
Gillespie GM, Quastel MN, McMichael AJ.
europepmc   +1 more source

Hantaan virus-derived peptides that stabilize HLA-E could abrogate inhibition of CD56dimNKG2A+ NK cells. [PDF]

PLoS Pathog
Xue M, Tang K, Zhang Y, Xu X, Zhang C, Zuo J, Wang F, Zhang X, Zheng X, Zhuang R, Zhang Y, Jin B, Ma Y.   +12 more
europepmc   +1 more source

Establishment of Immune-Evasive iPSCs from PBMCs Using B2M Knockout and CD47/HLA-E Overexpression. [PDF]

Tissue Eng Regen Med
Kim CY, Jeong C, Jeong YJ, Sung YH, Han Y, Hwang C.   +5 more
europepmc   +1 more source

The Novel HLA-E*01:152 Allele Identified in African Populations Using Next-Generation Sequencing. [PDF]

HLA
Naidoo N, Ng'uni TL, Padia U, Banjoko AW, Ndhlovu ZM.   +4 more
europepmc   +1 more source

Emerging roles of natural killer cell ligands-HLA-E, HLA-F, HLA-G, MICA, and MICB-in <i>in vitro</i> fertilization outcomes. [PDF]

Front Genet
Chaaithanya IK, Rajalingam R.
europepmc   +1 more source

HLA-E/peptide complexes differentially interact with NKG2A/CD94 and T cell receptors. [PDF]

J Immunol
Voogd L, van den Broek RL, van Wolfswinkel M, Franken KLMC, Ruibal P, Jespers W, Leitner J, Steinberger P, van Westen GJP, Ottenhoff THM, Joosten SA.   +10 more
europepmc   +1 more source

Stratifying Multiple Sclerosis Susceptibility Risk: The Role of HLA-E*01 and Infectious Mononucleosis in a Population Cohort. [PDF]

Eur J Neurol
Nova A, Gentilini D, Di Caprio G, Bourguiba-Hachemi S, Vince N, Gourraud PA, Bernardinelli L, Fazia T.   +7 more
europepmc   +1 more source

An In-Depth Review of the Genetics of the Non-Classical HLA Class I Gene HLA-E and Its Effects on Haematopoietic Cell Transplant Outcomes. [PDF]

HLA
Lucas JAM, Marsh SGE, Mayor NP.
europepmc   +1 more source

Targeting the HLA-E-NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG. [PDF]

J Exp Clin Cancer Res
Deng Y, Liu J, Pu Z, Wang Y, Li T, Jiang Z, Xie L, Zhang X, Chen Y, Yang M, Du C, Hao S, Ji N, Zhuang Z, Feng J, Zhang L.   +15 more
europepmc   +1 more source